Novo Nordisk records US$ 1.5 billion sales in Q1 2024, fueled by obesity drug
DENMARK -Novo Nordisk, a pharmaceutical powerhouse, has kickstarted 2024 with robust sales and...
Read More
Tag: Obesity
Global obesity rate surpasses 1 billion, WHO study reveals
USA— A recent study published in The Lancet reveals alarming trends in global obesity, indicating...
Read More
Amgen’s breakthrough obesity drug AMG 133 sparks investor frenzy
During Amgen’s recent fourth-quarter earnings call conference on Tuesday, February 6, Wall Street analysts were enthusiastic about the prospects of AMG 133, an experimental GLP-1 drug intended for the treatment of obesity.
Read More
Novo Nordisk partners with Omega Therapeutics and Cellarity
DENMARK – Novo Nordisk has inked separate research collaboration agreements with Omega...
Read More
Roche ventures into lucrative weight-loss market with US$2.7 billion Carmot Therapeutics merger
SWITZERLAND — Swiss pharmaceutical giant Roche has strategically entered the competitive...
Read More
Novo Nordisk sues Wells Pharmacy Network over semaglutide compounded drugs
USA — Novo Nordisk has filed a lawsuit against Wells Pharmacy Network, alleging misleading...
Read More
Pfizer halts twice-daily Danuglipron study due to side effects, shifts focus to once-daily version
USA — Pharmaceutical giant Pfizer has abandoned the development of the twice-daily version of its...
Read More
Novo Nordisk explores flexible pricing options for weight-loss drug Wegovy
DENMARK — Novo Nordisk CEO, Lars Fruergaard Jørgensen, has announced that the Danish...
Read More
Novo Nordisk invests US$2.3 billion in French facility to meet high demand for weight-loss and diabetes drugs
FRANCE – Danish pharmaceutical giant Novo Nordisk has unveiled a substantial US$2.3 billion...
Read More
Pharmaceutical giants capitalize on soaring obesity rates with revolutionary weight-loss drugs
USA – Obesity rates in the United States have witnessed a relentless ascent for well over a...
Read More
LATEST DIGITAL MAGAZINE
